BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2005
View Archived Issues
Comparative in vitro data of doripenem's potent antimicrobial activity / News in Context
Read More
Preclinical antidiabetic efficacy of MB-06322, a selective inhibitor of fructose 1,6-bisphosphatase
Read More
Muraglitazar improves glycemic control and lipid profile of patients with type 2 diabetes
Read More
Vantas not approvable in Canada
Read More
Bayer to study longer-acting Kogenate product in phase I
Read More
Hexvix NDA submission
Read More
Halozyme files IND for Chemophase
Read More
FDA agrees to file and review NDA for Fibrillex
Read More
Fampridine-SR enters phase III MS study
Read More
AVI submits IND for phase Ib study of AVI-4065 for HCV
Read More
Ariad opens enrollment for phase II endometrial cancer study of AP-23573
Read More
Phase III Crohn's disease study of Tysabri meets endpoints
Read More
Novel integrase inhibitors with different pharmacophores discovered
Read More
Agents for HIV infection in early development
Read More
Various agents for use in the treatment of cancer revealed in recent patents
Read More
Update on abatacept in rheumatoid arthritis
Read More
New phase I data on APD-125 in insomnia
Read More
Faster onset of action reported for AERx iDMS in type 1 diabetes
Read More
Temsirolimus shows promise in the treatment of multiple sclerosis
Read More
Procyon Biopharma completes acquisition of Bioxalis Medica
Read More
EMEA completes review of COX-2 inhibitors
Read More
Not approvable letter for tipifarnib
Read More
NitroMed launches BiDil
Read More
GenPat77 discovers novel protein that regulates immune cell activation
Read More
Recent patents described novel dermatologic compounds
Read More
